Medtronic's (MDT) business for neuromodulation devices received an FDA warning letter related...

|About: Medtronic plc (MDT)|By:, SA News Editor

Medtronic's (MDT) business for neuromodulation devices received an FDA warning letter related mainly to the company's processes for handling complaints, MDT CFO Gary Ellis disclosed in a conference call, adding that he does not expect a material impact on financial results. (earlier: FQ1 results)